Signant collaborated with research teams at University Hospital Basel to adapt the Neurostatus-EDSS instrument for electronic administration in three Multiple Sclerosis studies to address these common challenges:

• Inconsistencies or unwanted variability in rater scoring and administration
• Missing, incomplete, or erroneous entries
• Inefficient, non-interactive review process

Learn how Signant’s eCOA solution helped the study teams administer the Neurostatus-EDSS electronically to improve data quality, optimize the review process, and reduce timelines as well as burdens on sites and participants.